3D Echocardiography Volumetric Measurements in Patients with or without Valvular Heart Disease


About this study

The purpose of this study is to determine if 3D volumetric measurements will allow more robust quantification of valvular heart disease severity.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients undergoing routine echocardiography

Exclusion Criteria:

  • Subjects with poor apical images
  • Patients with congenital heart anomalies
  • Patients with multivalvular disease



Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Sorin Pislaru, M.D., Ph.D.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer